PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.13
ESG score 90-95% of EYEN's 63.22. Bill Ackman would demand clear ESG improvement catalysts.
53.68
Similar environmental score to EYEN's 51.63. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
57.71
Social score below 80% of EYEN's 74.04. Jim Chanos would check for potential social license and litigation risks.
60.00
Governance score 90-95% of EYEN's 63.99. Bill Ackman would demand clear governance improvement catalysts.